Plus Therapeutics Inc (PSTV)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.03B
EV to revenue ratio (TTM)
18.19
EV to ebitda
29.14
Financial Performance
Revenue (TTM)
$0.01B
Gross profit (TTM)
-$0.00B
EBITDA
-$0.02B
Profitability
Operating margin (TTM)
-693.00%
Profit margin
-230.20%
Return on assets (TTM)
-73.80%
Return on equity (TTM)
-522.00%
Per Share Metrics
Revenue per share (TTM)
$1.12
EPS
$21.56
Diluted EPS (TTM)
$21.56
Book value
$1.74
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
0.18
Trailing P/E
0.18
Forward P/E
0.97
PEG ratio
2.45
Price to sales ratio (TTM)
5.14
Price to book ratio (TTM)
2.20
Growth
Quarterly earnings growth (YoY)
-2.90%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
1
Buy
3
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.42